MP
GRDN

Mangrove Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Mangrove Partners’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,249
Closed -$499K – 609
2026
Q1 		$499K Buy
+13,249
New +$433K 0.04% 201

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Mangrove Partners's GRDN Position: Q2 2026 in Review

Mangrove Partners sold out of Guardian Pharmacy Services (GRDN) in Q2 2026, closing a stake of 13,249 shares — an estimated $499K sold.

Mangrove Partners first reported a position in GRDN in Q1 2026 and held it in 1 quarter. The position peaked at $499K in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Mangrove Partners reported no remaining Guardian Pharmacy Services position as of Q2 2026 after selling out during the quarter.
  • Mangrove Partners sold 13,249 Guardian Pharmacy Services shares in Q2 2026, an estimated $499K.
  • Mangrove Partners first reported a position in Guardian Pharmacy Services in Q1 2026 and held it in 1 quarter.
  • Mangrove Partners's Guardian Pharmacy Services position peaked at $499K in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.